Completed OBSERVATIONAL NCT03690648

Genetic Factors and Immunological Determinism of Persistent Consequences of Chikungunya (CHIKGENE)

Genetic Factors and Immunological Determinism of Persistent Consequences of Chikungunya Fever: Genome-wide Association Study

Sponsor: Centre Hospitalier Universitaire de la Réunion

Conditions Chikungunya Fever

Interventions Blood collection Quality of life survey Saliva collection

Updated 9 times since 2018 Last updated: Aug 29, 2022 Started: Aug 1, 2018 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Chikungunya Fever and is currently completed. Centre Hospitalier Universitaire de la Réunion leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2022 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Dec 2021 — Sep 2022 [monthly]

Unknown Status

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status
Oct 2020 — Nov 2020 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Nov 2018 — Oct 2020 [monthly]

Recruiting

First recorded

Aug 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de la Réunion
Conservatoire national des Arts et Métiers

Data source: Centre Hospitalier Universitaire de la Réunion

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saint-Pierre, Reunion